These three high-level workstreams identify, discuss and prioritize key industry topics and challenges swiftly.
The workstreams focus on the modalities of:
- Cell therapy (including gene modified cell therapies)
- In vivo gene therapy
Challenges need a collaborative approach
The advanced therapies field continues to mature and learn. While there has been a downturn in record-breaking funding, there is a push for expansion and a growing list of approved products. These high level workstreams cover the range of modalities: cell therapy (including gene modified cell therapies), in vivo gene therapy and RNA.
Leveraging cross-industry expertise to solve problems quickly
Members leverage cross-industry expertise to gain a better understanding of common industry challenges and collaborate to solve problems more quickly. The teams provide an increased network of experts resulting in greater resource to solve challenges.
More related workstreams
Our workstreams focus on the areas with the greatest impact across the industry. Led by science, our members are problem-solving today’s sustainability issues. By working with the regulatory governance community, they are also creating future-ready outcomes for the industry.
To find out more about how BioPhorum can help your business, enter your details below and a member of our team will be in touch.